id,sequence,label,elisa_flags,source
abituzumab,QDISNYYTSQQGNTFPYT,0.0,0,jain2017_pnas
abrilumab,QGISSWGASQQANSFPWT,0.0,0,jain2017_pnas
adalimumab,QGIRNYAASQRYNRAPYT,0.0,0,jain2017_pnas
alemtuzumab,QNIDKYNTNLQHISRPRT,0.0,0,jain2017_pnas
alirocumab,QSVLYRSNNRNFWASQQYYTTPYT,0.0,0,jain2017_pnas
anifrolumab,QSVSSSFGASQQYDSSAIT,0.0,0,jain2017_pnas
atezolizumab,QDVSTASASQQYLYHPAT,0.0,0,jain2017_pnas
bapineuzumab,QSLLDSDGKTYLVSWQGTHFPRT,0.0,0,jain2017_pnas
basiliximab,SSRSYDTSHQRSSYT,0.0,0,jain2017_pnas
bavituximab,QDIGSSATSLQYVSSPPT,0.0,0,jain2017_pnas
belimumab,SLRSYYGKNSSRDSSGNHWV,1.0,6,jain2017_pnas
benralizumab,EDIINYHTSQQGYTLPYT,0.0,0,jain2017_pnas
bevacizumab,QDISNYFTSQQYSTVPWT,0.0,0,jain2017_pnas
bimagrumab,SSDVGSYNYGVSGTFAGGSYYGV,0.0,0,jain2017_pnas
blosozumab,QDVHTAWASQQYSDYPWT,1.0,6,jain2017_pnas
bococizumab,QGISSASASQQRYSLWRT,1.0,6,jain2017_pnas
brentuximab,QSVDFDGDSYAASQQSNEDPWT,,3,jain2017_pnas
briakinumab,RSNIGSNTYNDQSYDRYTHPALL,1.0,4,jain2017_pnas
brodalumab,QSVSSNDASQQYDNWPLT,,1,jain2017_pnas
canakinumab,QSIGSSYASHQSSSLPFT,0.0,0,jain2017_pnas
carlumab,QSVSDAYDASHQYIQLHSFT,1.0,4,jain2017_pnas
certolizumab,QNVGTNSASQQYNIYPLT,0.0,0,jain2017_pnas
cetuximab,QSIGTNYASQQNNNWPTT,0.0,0,jain2017_pnas
cixutumumab,SLRSYYGENKSRDGSGQHLV,1.0,6,jain2017_pnas
clazakizumab,QSINNERASQQGYSLRNIDNA,0.0,0,jain2017_pnas
codrituzumab,QSLVHSNRNTYKVSSQNTHVPPT,1.0,6,jain2017_pnas
crenezumab,QSLVYSNGDTYKVSSQSTHVPWT,0.0,0,jain2017_pnas
dacetuzumab,QSLVHSNGNTFTVSSQTTHVPWT,0.0,0,jain2017_pnas
daclizumab,SSISYTTSHQRSTYPLT,,1,jain2017_pnas
dalotuzumab,QSIVHSNGNTYKVSFQGSHVPWT,1.0,5,jain2017_pnas
daratumumab,QSVSSYDASQQRSNWPPT,0.0,0,jain2017_pnas
denosumab,QSVRGRYGASQQYGSSPRT,1.0,5,jain2017_pnas
dinutuximab,QSLVHRNGNTYKVSSQSTHVPPLT,0.0,0,jain2017_pnas
drozitumab,SLRSYYGANNSADSSGNHVV,0.0,0,jain2017_pnas
duligotuzumab,QNIATDSASQQSEPEPYT,1.0,6,jain2017_pnas
dupilumab,QSLLYSIGYNYLGSMQALQTPYT,1.0,5,jain2017_pnas
eculizumab,ENIYGAGATQNVLNTPLT,0.0,0,jain2017_pnas
efalizumab,KTISKYSGSQQHNEYPLT,0.0,0,jain2017_pnas
eldelumab,QSVSSSYGASQQYGSSPIFT,0.0,0,jain2017_pnas
elotuzumab,QDVGIAWASQQYSSYPYT,0.0,0,jain2017_pnas
emibetuzumab,SSVSSIYSTSQVYSGYPLT,1.0,6,jain2017_pnas
enokizumab,QHVITHGTSQQFYEYPLT,0.0,0,jain2017_pnas
epratuzumab,QSVLYSANHKNYWASHQYLSSWT,,1,jain2017_pnas
etrolizumab,ESVDDLYASQQGNSLPNT,,2,jain2017_pnas
evolocumab,SSDVGGYNSEVSNSYTSTSMV,,2,jain2017_pnas
farletuzumab,SSISSNNGTSQQWSSYPYMYT,0.0,0,jain2017_pnas
fasinumab,QAIRNDAAFQQYNRYPWT,0.0,0,jain2017_pnas
fezakinumab,SSNIGAGYGGDSQSYDNSLSGYV,0.0,0,jain2017_pnas
ficlatuzumab,ENVVSYGASGQSYNYPYT,0.0,0,jain2017_pnas
figitumumab,QGIRNDAASLQHNSYPCS,,3,jain2017_pnas
fletikumab,QGISSADASQQFNSYPLT,0.0,0,jain2017_pnas
foralumab,QSVSSYDASQQRSNWPPLT,,2,jain2017_pnas
fresolimumab,QSLGSSYGASQQYADSPIT,0.0,0,jain2017_pnas
fulranumab,QGISSADASQQFNSYPLT,,1,jain2017_pnas
galiximab,TSNIGGYDDINQSYDSSLNAQV,0.0,0,jain2017_pnas
ganitumab,QSLLHSNGYNYLGSMQGTHWPLT,0.0,0,jain2017_pnas
gantenerumab,QSVSSSYGASLQIYNMPIT,1.0,6,jain2017_pnas
gemtuzumab,ESLDNYGIRFAASQQTKEVPWS,0.0,0,jain2017_pnas
gevokizumab,QDISNYYTSLQGKMLPWT,0.0,0,jain2017_pnas
girentuximab,QNVVSASASQQYSNYPWT,0.0,0,jain2017_pnas
glembatumumab,QSVDNNGASQQYNNWPPWT,0.0,0,jain2017_pnas
golimumab,QSVYSYDASQQRSNWPPFT,,1,jain2017_pnas
guselkumab,SSNIGSGYDGNSASWTDGLSLVV,,1,jain2017_pnas
ibalizumab,QSLLYSTNQKNYWASQQYYSYRT,0.0,0,jain2017_pnas
imgatuzumab,QGINNYNTNLQHNSFPT,1.0,5,jain2017_pnas
infliximab,QFVGSSYASQQSHSWPFT,0.0,0,jain2017_pnas
inotuzumab,QSLANSYGNTFGISLQGTHQPYT,,3,jain2017_pnas
ipilimumab,QSVGSSYGAFQQYGSSPWT,0.0,0,jain2017_pnas
ixekizumab,RSLVHSRGNTYKVSSQSTHLPFT,1.0,6,jain2017_pnas
lampalizumab,TDIDDDGGNLQSDSLPYT,0.0,0,jain2017_pnas
lebrikizumab,KSVDSYGNSFLASQQNNEDPRT,0.0,0,jain2017_pnas
lenzilumab,QSVGTNSTSQQFNKSPLT,1.0,6,jain2017_pnas
lintuzumab,ESVDNYGISFAASQQSKEVPWT,0.0,0,jain2017_pnas
lirilumab,QSVSSYDASQQRSNWMYT,0.0,0,jain2017_pnas
lumiliximab,QDIRYYVASLQVYSTPRT,0.0,0,jain2017_pnas
matuzumab,SSVTYDTSQQWSSHIFT,0.0,0,jain2017_pnas
mavrilimumab,GSNIGAPYDHNNATVEAGLSGSV,0.0,0,jain2017_pnas
mepolizumab,QSLLNSGNQKNYGASQNVHSFPFT,0.0,0,jain2017_pnas
mogamulizumab,RNIVHINGDTYKVSFQGSLLPWT,0.0,0,jain2017_pnas
motavizumab,SRVGYDTSFQGSGYPFT,,1,jain2017_pnas
muromonab,SSVSYDTSQQWSSNPFT,0.0,0,jain2017_pnas
natalizumab,QDINKYYTSLQYDNLWT,0.0,0,jain2017_pnas
necitumumab,QSVSSYDASHQYGSTPLT,0.0,0,jain2017_pnas
nimotuzumab,QNIVHSNGNTYKVSFQYSHVPWT,0.0,0,jain2017_pnas
nivolumab,QSVSSYDASQQSSNWPRT,0.0,0,jain2017_pnas
obinutuzumab,KSLLHSNGITYQMSAQNLELPYT,0.0,0,jain2017_pnas
ocrelizumab,SSVSYAPSQQWSFNPPT,0.0,0,jain2017_pnas
ofatumumab,QSVSSYDASQQRSNWPIT,0.0,0,jain2017_pnas
olaratumab,QSVSSYDASQQRSNWPPA,0.0,0,jain2017_pnas
olokizumab,QDIGISNANLQHNSAPYT,0.0,0,jain2017_pnas
omalizumab,QSVDYDGDSYAASQQSHEDPYT,0.0,0,jain2017_pnas
onartuzumab,QSLLYTSSQKNYWASQQYYAYPWT,0.0,0,jain2017_pnas
otelixizumab,SGNIENNYDDDHSYVSSFNV,0.0,0,jain2017_pnas
otlertuzumab,ENVYSYFAKQHHSDNPWT,0.0,0,jain2017_pnas
ozanezumab,KSLLYKDGKTYLMSQQLVEYPLT,,3,jain2017_pnas
palivizumab,LSVGYDTSFQGSGYPFT,0.0,0,jain2017_pnas
panitumumab,QDISNYDASQHFDHLPLA,0.0,0,jain2017_pnas
panobacumab,QSLVYSDGNTYKVSMQGTHWPLT,0.0,0,jain2017_pnas
parsatuzumab,QSLVHINAITYRVSGQSTHVPLT,1.0,6,jain2017_pnas
patritumab,QSVLYSSSNRNYWASQQYYSTPRT,1.0,4,jain2017_pnas
pembrolizumab,KGVSTSGYSYLASQHSRDLPLT,0.0,0,jain2017_pnas
pertuzumab,QDVSIGSASQQYYIYPYT,0.0,0,jain2017_pnas
pinatuzumab,QSIVHSVGNTFKVSFQGSQFPYT,0.0,0,jain2017_pnas
polatuzumab,QSVDYEGDSFAASQQSNEDPLT,0.0,0,jain2017_pnas
ponezumab,QSLLYSDAKTYQISLQGTHYPVL,1.0,4,jain2017_pnas
radretumab,QSVSSSFYASQQTGRIPPT,0.0,0,jain2017_pnas
ramucirumab,QGIDNWDASQQAKAFPPT,0.0,0,jain2017_pnas
ranibizumab,QDISNYFTSQQYSTVPWT,,1,jain2017_pnas
reslizumab,EGISSYGANQQSYKFPNT,0.0,0,jain2017_pnas
rilotumumab,QSVDSNGASQQYINWPPIT,0.0,0,jain2017_pnas
rituximab,SSVSYATSQQWTSNPPT,0.0,0,jain2017_pnas
robatumumab,QSIGSSYASHQSSRLPHT,1.0,4,jain2017_pnas
romosozumab,QDISNYYTSQQGDTLPYT,0.0,0,jain2017_pnas
sarilumab,QGISSWGASQQANSFPYT,0.0,0,jain2017_pnas
secukinumab,QSVSSSYGASQQYGSSPCT,0.0,0,jain2017_pnas
seribantumab,SSDVGSYNVEVSCSYAGSSIFVI,0.0,0,jain2017_pnas
sifalimumab,QSVSSTYGASQQYGSSPRT,,3,jain2017_pnas
siltuximab,SSVSYDTSQQWSGYPYT,0.0,0,jain2017_pnas
simtuzumab,KSLLHSNGNTYRMSMQHLEYPYT,1.0,6,jain2017_pnas
sirukumab,ISVSYDMSMQWSGYPYT,1.0,5,jain2017_pnas
tabalumab,QSVSRYDASQQRSNWPRT,0.0,0,jain2017_pnas
tanezumab,QSISNNYTSQQEHTLPYT,,1,jain2017_pnas
teplizumab,SSVSYDTSQQWSSNPFT,,2,jain2017_pnas
tigatuzumab,QDVGTAWASQQYSSYRT,0.0,0,jain2017_pnas
tildrakizumab,ENIYSYNAKQHHYGIPFT,0.0,0,jain2017_pnas
tocilizumab,QDISSYYTSQQGNTLPYT,0.0,0,jain2017_pnas
tovetumab,QSFSRYAASQQTYSNPPIT,0.0,0,jain2017_pnas
tralokinumab,IIGSKLDDGQVWDTGSDPVV,0.0,0,jain2017_pnas
trastuzumab,QDVNTASASQQHYTTPPT,0.0,0,jain2017_pnas
tremelimumab,QSINSYAASQQYYSTPFT,0.0,0,jain2017_pnas
urelumab,QSVSSYDASQQRSNWPPALT,0.0,0,jain2017_pnas
ustekinumab,QGISSWAASQQYNIYPYT,,3,jain2017_pnas
vedolizumab,QSLAKSYGNTYGISLQGTHQPYT,0.0,0,jain2017_pnas
veltuzumab,SSVSYATSQQWTSNPPT,0.0,0,jain2017_pnas
visilizumab,SSVSYDTSQQWSSNPPT,,3,jain2017_pnas
zalutumumab,QDISSADASQQFNSYPLT,,1,jain2017_pnas
zanolimumab,QDISSWAASQQANSFPYT,0.0,0,jain2017_pnas
